Facebook today appealed the Irish High Court’s decision to pass the web giant's legal battle with Max Schrems over privacy rights to the European Union’s top court.

Schrems has said previously that he expected Facebook to issue a series of appeals against the decisions, and lamented both the costs involved and the lack of hard deadlines within Irish law to stop delay tactics.

In a confidence-building gesture ahead of a proposed summit meeting with President Trump, a suddenly loquacious and conciliatory Mr. Kim also said he would invite experts and journalists from South Korea and the United States to watch the shutdown next month of his country’s only known underground nuclear test site.

But skeptics warned that North Korea previously made similar pledges of denuclearization on numerous occasions, with little or no intention of abiding by them. Mr. Kim’s friendly gestures, they said, could turn out to be nothing more than empty promises aimed at lifting sanctions on his isolated country.

The Silicon Valley giant told America's financial watchdog, the SEC, on Thursday that it will probably reveal additional data-harvesting operations as it continues probing how outside developers accessed its website and what information they siphoned off in bulk.

Now after years of letting companies chug from its firehose, Facebook is shocked – shocked – to discover that shady outfits were amassing folks' info via these APIs.

The $9.95 monthly subscription service, known for letting you watch as many movies in participating theaters as you want, just added a big, fat limit to its terms: You can now watch the same movie only once, not over and over again.

The firm has tweeted that it was "evolving" its designs to better reflect its values, and intended to substitute a graphic of a revolver with that of a water pistol.

Critics have warned that deviating from the norm may lead to messages being misunderstood.

China had about 99 percent of the 385,000 electric buses on the roads worldwide in 2017, accounting for 17 percent of the country’s entire fleet. Every five weeks, Chinese cities add 9,500 of the zero-emissions transporters—the equivalent of London’s entire working fleet, according Bloomberg New Energy Finance.

For every 1,000 battery-powered buses on the road, about 500 barrels a day of diesel fuel will be displaced from the market, according to BNEF calculations.

TSB's IT fiasco is heading for a fifth day, with angry customers still locked out of their accounts and unable to make payments.

It promised that systems would be back up and running by 6pm on Sunday but many of those who did get access to their online accounts were presented with details of other people's accounts too.

Nicky Morgan MP, chair of the Treasury Committee, weighed into the crisis on Tuesday by writing to TSB boss Paul Pester to find out what has gone wrong, the extent of the failure, and how the bank intends to compensate customers who have suffered a breach of potentially highly-sensitive personal data.

While Apple CEO Tim Cook commented in a recent interview that he would never allow his company to get itself in the heinous situation in which Facebook finds itself, because, one inferred, it was a more moral company.

Google came second with 15 percent. Apple's 11 percent put it third. Oddly, Uber scored higher than Netflix, Twitter, Snap and, oh, Lyft.

"Excessive automation at Tesla was a mistake," Musk tweeted recently. "To be precise, my mistake. Humans are underrated."

Robots are supposed to allow production of more cars with fewer workers, but one ironic consequence of over-automation is that it can actually require more workers. Ingrassia and White report that GM's Hamtramck plant had around 5,000 workers on its payroll in the mid-1980s, compared to 3,700 workers at a nearby Ford plant with many fewer robots. Yet the Ford plant was "outproducing Hamtramck by a wide margin."

Taking just one pill a day could dramatically reduce costs to around $50,000 a year. And it could lessen unpleasant side-effects, such as diarrhea, muscle and bone pain, and tiredness. But just as doctors were gearing up for more trials on the lower dosages, the makers of the drug revealed plans that torpedoed the doctors’ efforts: they were tripling the price of the drug and changing pill dosages.

Imbruvica’s makers, Janssen and Pharmacyclics, have now gotten approval to sell four different tablets of varying strengths: 140mg, 280mg, 420mg, and 560mg. But the new pills will all be the same price—around $400 each—even the 140mg dose pill.